computational pathology

The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.

The new funds will be put towards growing its diagnostic and testing products. 

Health Venture Partners led the round with participation from Breyer Capital, Kenan Turnacioglu and other funders.

The algorithm used by the Ibex Second Read system was developed using advanced machine learning techniques and trained on data sets from Maccabi's pathology institute.

Ibex Medical Analytics, an Israel-based startup founded in 2016 which is developing their own AI-driven computational pathology cancer diagnosis system, recently completed an $11M Series A funding round led by aMoon Fund.